Buscar resultados de ensayos clínicos
Congenital Cytomegalovirus - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening Condición: Congenital Cytomegalovirus Infection Fecha: 2014-04-28 Intervenciones: Other: CMV PCR Other Name: CMV PCR results are communicated to the relevant clinicians in real time. |
Recruiting |
Nombre del estudio: Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV Condición: Congenital Cytomegalovirus Infection Fecha: 2016-05-23 Intervenciones: Other: olfactory tests, otoacoustic emissions (OAE) Two series of olfactory tests will be performed : 1) |
Terminated |
Nombre del estudio: Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial Condición:
|
Recruiting |
Nombre del estudio: Congenital Cytomegalovirus: Efficacy of Antiviral Treatment Condición:
|
Recruiting |
Nombre del estudio: A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV) Condición:
|
Not yet recruiting |
Nombre del estudio: Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance Condición: Congenital Cytomegalovirus (CMV) Fecha: 2015-11-05 Intervenciones: Drug: Valganciclovir Oral valganciclovir (Rovalcyte 50 mg/ml, powder for oral suspension) at a dose of 1 |
Recruiting |
Nombre del estudio: Congenital CMV and Hearing Loss in Children up to 4 Years of Age: Treating With Valganciclovir Therapy Condición:
Fecha: 2012-07-20 Intervenciones:
|
Recruiting |
Nombre del estudio: A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China Condición: Congenital Cytomegalovirus Infection Fecha: 2016-03-05 |
Recruiting |
Nombre del estudio: Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy Condición: Congenital Cytomegalovirus Infection Fecha: 2015-01-18 Intervenciones:
|
Withdrawn |
Nombre del estudio: Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine Condición: Congenital Cytomegalovirus Infection Fecha: 2015-10-16 Intervenciones: Drug: CyMVectin CyMVectin will be delivered by unilateral intramuscular (IM) injection at Day 0, Day 28( |